Presentation, patterns of care, and survival in patients with brain metastases: What has changed in the last 20 years?

Cancer

Volumn 117, Issue 11, 2011, Pages 2505-2512

  Nieder, Carsten ^a,b   Spanne, Oddvar ^c   Mehta, Minesh P ^d   Grosu, Anca L ^e   Geinitz, Hans ^f  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Brain metastases; Chemotherapy; Prognostic factors; Radiotherapy; Surgery

Indexed keywords

HORMONE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; STEREOTAXIC SURGERY;

BRAIN METASTASES; CHEMOTHERAPY; PROGNOSTIC FACTORS; RADIOTHERAPY; SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DATABASES, FACTUAL; FEMALE; GERMANY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MIDDLE AGED; MORTALITY; NORWAY; RETROSPECTIVE STUDIES; STANDARD OF CARE;

EID: 79956215071     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25707     Document Type: Article

References (24)

1. Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol. 2005;23:6207-6219.
2. Nieder C, Pawinski A, Haukland E, Dokmo R, Phillipi I, Dalhaug A. Estimating need for palliative external beam radiotherapy in adult cancer patients. Int J Radiat Oncol Biol Phys. 2010;76:207-211.
3. Nieder C, Norum J, Stemland JG, Dalhaug A. Resource utilization in patients with brain metastases managed with best supportive care (BSC), radiotherapy (RT) and/or surgical resection (SR). A Markov analysis. Oncology. 2010;78:348-355.
4. Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:17-32.
5. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:33-43.
6. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:45-68.
7. Nieder C, Pawinski A, Molls M. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? Clin Oncol (R Coll Radiol). 2010;22:65-69.
8. Nieder C, Marienhagen K, Geinitz H, Molls M. Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncol. 2009;48:457-459.
9. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510-514.
10. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745-751. (Pubitemid 27181303)
11. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665-1672. (Pubitemid 38670323)
12. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45:427-434. (Pubitemid 29408559)
13. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity. Int J Radiat Oncol Biol Phys. 1994;29:711-717. (Pubitemid 24241310)
14. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494-500. (Pubitemid 20067825)
15. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43:795-803. (Pubitemid 29152652)
16. Knisely JP, Berkey B, Chakravarti A, et al. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). Int J Radiat Oncol Biol Phys. 2008;71:79-86.
17. Rades D, Kueter JD, Veninga T, Gliemroth J, Schild SE. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pairs analysis. Eur J Cancer. 2009;45:400-404.
18. Rades D, Kueter JD, Hornung D, et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol. 2008;184:655-662.
19. Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006;24:106-114. (Pubitemid 46630501)
20. Wakelee HA, Bernardo P, Johnson DH, Schiller JH. Changes in the natural history of nonsmall cell lung cancer (NSCLC) - comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer. 2006;106:2208-2217. (Pubitemid 43673243)
21. Yawn BP, Wollan PC, Schroeder C, Gazzuola L, Mehta M. Temporal and gender-related trends in brain metastases from breast and lung cancer. Minn Med. 2003;86:32-37.
22. Nobauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, et al. Magnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 tesla. Invest Radiol. 2002;37:114-119. (Pubitemid 34225507)
23. Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22:1293-1300. (Pubitemid 41079844)
24. Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer. 2009;101:1919-1924.